KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer. - Loupakis,F.; Ruzzo,A.; Cremolini,C. (Br J Cancer, 2009)